| | |
Vijaya Rathore 01:15 AM | November 02,2009
Lower commodity rates allowed these firms to divert more funds for advertising and sales promotions in Jul-Sep
|
|
Reuters 03:02 PM | October 27,2009
Oil giant BP was the major driver of blue-chip gains, up 4.7% after it reported a halving of third-quarter profits but beat forecasts by a wide margin
|
|
Reuters 01:32 PM | October 26,2009
Banks featured among the best performers. Banco Santander, Deutsche Bank, BNP Paribas and UniCredit were up 0.6 to 1.1%
|
|
Reuters 11:45 AM | October 24,2009
Sanofi said it has shipped 12 million of the 16.1 million vaccine doses the US government had received as of Friday
|
|
Mark to Market | Manas chakravarty, Ravi Ananthanarayanan and Vatsala Kamat 01:15 AM | October 12,2009
IMS Health, a global pharmaceutical market research company, has released its latest forecast for 2010, in which it projects the global pharmaceutical market to grow by 4-6%
|
|
Shamnad Basheer 09:33 PM | October 11,2009
Recent alliances such as Ranbaxy-Daiichi, Indian generics firms are now acquiring dual personalities and speaking the language of patents and innovation
|
|
Ben Hirschler / Reuters 03:06 PM | October 06,2009
149 million doses ordered since August, total now 440 million; implies booked orders to date worth around $3.5 billion; discussions continue with governments for further supplies
|
|
Reuters 05:03 PM | September 29,2009
GlaxoSmithKline won support for its cervical cancer vaccine from an advisory panel to Japan’s Health Ministry, putting it on track to be the first to offer such a vaccine in the world’s second-biggest drug market
|
|
Reuters 07:42 PM | September 28,2009
Lucozade is predominantly sold in Britain, Ireland, and Hong Kong will now be sold in China
|
|
Reuters 04:40 PM | September 23,2009
Weak dollar underpins commodity gains; Liberty leads property stocks lower after share placing; British data mixed but investors await Fed decision
|
|
Reuters 05:16 PM | September 18,2009
But supply fears have eased with major drug manufacturers reporting that a single dose is successful in providing immunity
|
|
Sumeet Chatterjee and Ben Hirschler / Reuters 03:09 PM | September 18,2009
Deal would be win-win for both drugmakers, say analysts
|
|
Radhieka Pandeya 12:37 AM | August 28,2009
The government’s move will allow people to buy Oseltamivir from designated chemists and other distribution channels if they have a prescription
|
|
Reuters 05:27 PM | August 18,2009
With this, Glenmark has four first-to-file products under litigation under the Hatch-Waxman Act, it said in a statement to the Bombay Stock Exchange
|
|
C.H. Unnikrishnan 10:08 PM | August 09,2009
Low costs, high technical capabilities and a skilled work force are making India an attractive destination for research and contract manufacturing of drugs
|
|